UPDATE: Benchmark Downgrades ICU Medical to Hold on Valuation
In a report published Thursday, Benchmark Company analyst James Terwilliger downgraded the rating on ICU Medical (NASDAQ: ICUI) from Buy to Hold, but reiterated the $69.00 price target.
In the report, Terwilliger noted, “We are lowering our recommendation to Hold from Buy based on valuation as ICU Medical has traded close to our $69.00 price target. Our $69.00 price target represents 20 times our 2013 EPS estimate of $2.80 plus $13.00 in cash per share. We remind investors that ICU Medical has a strong balance sheet with approximately $16.00 in cash per share and no long-term debt. We believe that ICU Medical could be exploring a sale of the company, according to a Bloomberg News report.”
ICU Medical closed on Wednesday at $68.80.
Latest Ratings for ICUI
Date | Firm | Action | From | To |
---|---|---|---|---|
Feb 2021 | Raymond James | Maintains | Outperform | |
Feb 2021 | Raymond James | Maintains | Outperform | |
Jan 2021 | KeyBanc | Maintains | Overweight |
View More Analyst Ratings for ICUI
View the Latest Analyst Ratings
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Benchmark CompanyAnalyst Color Downgrades Analyst Ratings